BATF2 and nasopharyngeal carcinoma: Interestingly, the sensitivity, specificity, and AUC value of plasma-derived sEV BATF2 in distinguishing between NPC patients and healthy controls were 81%, 82%, and 0.8983, respectively (Cui et al., 2021).